Politiparty
Politiparty

118th Congress Health

H.R. 1199: Facilitating Innovative Nuclear Diagnostics Act of 2023

Introduced

  1. Introduced (completed)Feb 27, 2023
  2. Passed House (not reached)
  3. Passed Senate (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in House, Feb 27, 2023

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

47

Bipartisan support.

Who scored on this bill

12 points earned
  1. 1Neal Dunn R-FL SponsorDrew cross-party cosponsors, introduced, reached a cosponsor milestone3 events+12
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Neal Dunn

History

  1. Feb 27, 2023Introduced in the House by Neal Dunn.
Show the full action history (5 actions)
  1. May 16, 2024Subcommittee Consideration and Mark-up Session Held
  2. May 16, 2024Forwarded by Subcommittee to Full Committee by Voice Vote.
  3. Mar 10, 2023Referred to the Subcommittee on Health.
  4. Feb 27, 2023Introduced in House
  5. Feb 27, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.